Status:
COMPLETED
iPS Cells of Patients for Models of Retinal Dystrophies
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Retinal Dystrophies
Eligibility:
All Genders
5-70 years
Phase:
NA
Brief Summary
The investigators are focused on inherited retinal dystrophies with an aim to further understand disease pathophysiology and to elaborate novel treatments, as, to date, there is no effective treatment...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Signed informed consent and
- Choroideremia :
- Males
- CHM mutation
- With multimodal Imaging anomalies in line with CHM
- All other presumed inherited retinal dystrophies with bilateral and symmetrical involvement with identified mutations in one of the Retnet gene
- All presumed inherited optic neuropathy with bilateral and symmetrical involvement with identified mutations
- And in all cases or pattern
- Age from 5 to 70
- with appropriate health insurance
- Exclusion criteria :
- Patient under tutorship or curatorship
Exclusion
Key Trial Info
Start Date :
November 3 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03853252
Start Date
November 3 2014
End Date
October 30 2023
Last Update
July 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CNMR Maolya, Genetic Sensory Diseases
Montpellier, Occitanie, France, 34294